NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors
Clinical trial NCT00299728 · COMPLETED
Trial details
- NCT number
- NCT00299728
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-21
- Primary completion
- 2006-10-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.